COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 2304: Articles 23031-23040  | Next

Longitudinal SARS-CoV-2 serosurveillance of over ten thousand health care workers in the Providence Oregon cohort.
Leidner, R., Frary, A., Cramer, J., Ball, D., Weerasinghe, R., Schmidt, M., Jin, J., Luzzi, V., Saitman, A., Young, J. A., Leidner, D., Sawa, K., Marsal, S., Olson, K., Frisco, N., Compton-Phillips, A., Urba, W., Piening, B., Bifulco, C.
10.1101/2020.08.16.20176107 — Posted: 2020-08-18
Protection Level and Reusability of a Modified Full-Face Snorkel Mask as Alternative Personal Protective Equipment for Healthcare Workers During the COVID-19 Pandemic
Schmitt, J., Jones, L. S., Aeby, E. A., Gloor, C., Moser, B., Wang, J.
10.1101/2020.08.16.20176081 — Posted: 2020-08-18
Study of Coronavirus Impact on Parisian Population from April to June using Twitter and Text Mining Approach
Chire Saire, J. E., Oblitas Cruz, J. F.
10.1101/2020.08.15.20175810 — Posted: 2020-08-18 Discussion: Onsite
Evolving Virulence? Decreasing COVID-19 Complications among Massachusetts Healthcare Workers: A Cohort Study
Lan, F.-Y., Filler, R., Mathew, S., Iliaki, E., Osgood, R., Bruno-Murtha, L. A., Kales, S. N.
10.1101/2020.08.17.20176636 — Posted: 2020-08-18 Discussion: Onsite
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19
Anderson, E. M., Diorio, C., Goodwin, E. C., McNerney, K. O., Weirick, M. E., Gouma, S., Bolton, M. J., Arevalo, C. P., Chase, J., Hicks, P., Manzoni, T. B., Baxter, A. E., Andrea, K. P., Burudpakdee, C., Lee, J. H., Vella, L. A., Henrickson, S. E., Harris, R. M., Wherry, E. J., Bates, P., Bassiri, H., Behrens, E. M., Teachey, D. T., Hensley, S.
10.1101/2020.08.17.20176552 — Posted: 2020-08-18
Quantifying the efficiency of non-pharmaceutical interventions against SARS-COV-2 transmission in Europe
Garchitorena, A., Gruson, H., Cazelles, B., ROCHE, B.
10.1101/2020.08.17.20174821 — Posted: 2020-08-18
End-to-End Protocol for the Detection of SARS-CoV-2 from Built Environments
Parker, C. W., Singh, N., Tighe, S., Blachowicz, A., Wood, J. M., Seuylemezian, A., Vaishampayan, P., Urbaniak, C., Hendrickson, R., Laaguiby, P., Clark, K., Clement, B. G., O'Hara, N. B., Couto-Rodriguez, M., Bezdan, D., Mason, C., Venkateswaran, K.
10.1101/2020.08.16.20172668 — Posted: 2020-08-18
Investigation into Quality of Life and Psychological Status of Different Populations during COVID-19 : A study concerning Surrounding Areas of Wuhan
Liu, Z., Mu, J., Fan, W.
10.1101/2020.08.15.20158725 — Posted: 2020-08-18
Multisystem inflammatory syndrome in children related to COVID-19: A systematic review
Hoste, L., Van Paemel, R., Haerynck, F.
10.1101/2020.08.17.20173641 — Posted: 2020-08-18
Data-Driven Development of a Small-Area COVID-19 Vulnerability Index for the United States
amram, o., Amiri, S., Thorn, E. L., Mansfield, J. J., Mellacheruvu, P., Monsivais, P.
10.1101/2020.08.17.20176248 — Posted: 2020-08-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).